Microcap Ledger Lifevantage Corp $LFVN
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Lehi, UT
- Fiscal year end
- December 31
- Shares outstanding
- 12,527,348 [10-K 2026-08-27]
What the company doesAI summary of filing
LifeVantage Corporation develops and sells nutrigenomic dietary supplements, skin and hair care products, and energy/hydration drink mixes through a direct sales model using independent consultants. The company generates revenue by selling these products to customers and independent consultants in 18 countries across North America, Europe, Asia-Pacific, and through a global customer acquisition program for personal consumption. LifeVantage is revenue-generating, with product lines including Protandim (antioxidant supplements), LifeVantage (wellness supplements including weight management), TrueScience (skin and hair care), P84 System (gut health), Petandim (pet supplements), and AXIO (energy/hydration drinks). [10-K 2026-08-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| FY ended Jun 2026 | $182.59M | $5.07M | $10.24M | $14.92M | [10-K 2026-08-27] |
| FY ended Jun 2025 | $228.53M | $9.80M | $11.88M | $20.20M | [10-K 2026-08-27] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-28 | 12,525,229 | [10-Q 2024-10-29] |
| 2025-02-04 | 12,551,281 | [10-Q 2025-02-05] |
| 2025-05-05 | 12,588,183 | [10-Q 2025-05-06] |
| 2025-09-03 | 12,691,009 | [10-K 2025-09-04] |
| 2025-11-03 | 12,701,187 | [10-Q 2025-11-04] |
| 2026-02-03 | 12,793,359 | [10-Q 2026-02-04] |
| 2026-05-04 | 12,615,822 | [10-Q 2026-05-06] |
| 2026-08-26 | 12,527,348 | [10-K 2026-08-27] |
- Shelf registration
- S-3 filed 2026-03-10; declared effective 2026-03-20 [S-3 2026-03-10]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-10-07 | Cunningham Kristen | grant | 32,850 | — | [4 2026-10-09] |
| 2026-10-07 | Aure Carl | grant | 35,749 | — | [4 2026-10-09] |
| 2026-10-07 | Moorehead Terrence | grant | 193,237 | — | [4 2026-10-09] |
| 2026-10-01 | Aure Carl | other | 460 | $6.24 | [4 2026-10-05] |
| 2026-10-01 | Cunningham Kristen | other | 637 | $6.24 | [4 2026-10-05] |
| 2026-09-15 | Lewis Darwin | buy | 976 | $6.22 | [4 2026-09-17] |
| 2026-09-14 | Cunningham Kristen | sell | 8,901 | $6.18 | [4 2026-09-14] |
| 2026-09-11 | Cunningham Kristen | sell | 100 | $6.41 | [4 2026-09-14] |
| 2026-09-10 | Aure Carl | other | 1,869 | $6.37 | [4 2026-09-14] |
| 2026-09-10 | Cunningham Kristen | other | 2,254 | $6.37 | [4 2026-09-14] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-05 | 8-K | Charter, bylaws or fiscal year change |
| 2026-09-18 | DEF 14A | Proxy statement |
| 2026-08-27 | 8-K | Results of operations |
| 2026-08-27 | 10-K | Annual report |
| 2026-08-13 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-03 | 8-K | Director or officer change |
| 2026-07-29 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-06 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-06 | 8-K | Results of operations |
| 2026-05-06 | 10-Q | Quarterly report |
| 2026-04-16 | 8-K | Director or officer change |
| 2026-04-02 | 13G/A | Beneficial ownership report (5%+ holder) |
Alerts for $LFVN
Email me when Lifevantage Corp files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.